Accium BioSciences, Inc.

Comarketing agreement signed for spectrometry services

Published in Law and Health Weekly, July 16th, 2005

Accium BioSciences, Inc., the first U.S. company to develop a fully commercial analytical facility dedicated to Accelerator Mass Spectrometry (AMS) services, has forged a new strategic co-marketing agreement with Radiant Research, Inc., (Radiant).

This agreement combines Accium's expertise in AMS-based study design and in-house analytical services with Radiant's state-of-the-art clinical trials facilities to provide pharmaceutical researchers with comprehensive phase 0 (microdosing) and low radiation phase I clinical services nationwide.

"For the first time, this partnership provides our pharmaceutical sponsors with a one-stop solution for both the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly

Source: Law and Health Weekly (2005-07-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry